Sinovac Biotech Ltd. Expects To Complete Human Influenza Vaccine Pre-Clinical Research By 200-End

March 24, 2004 | Print | Email Email | Comments | Category: Science



    Sinovac Biotech Ltd. (Sinovac) has announced that it has initiated the Inactivated New Human Influenza (H5N1) Vaccine Research and Development Project.

    Based on the protocol, it is expected to finish pre-clinical research by the end of this year. A professional workshop was held by the Chinese "Bird-Human Infection Prevention and Control Team" in Beijing on Feb. 11, 2004. Mr. Xiaoping DONG and Mr. Dexin Li from China CDC and Dr. Weidong Yin, President of Sinovac Biotech Ltd., presented the "New Human Influenza Vaccine Research and Development Protocol." The Control Team subsequently decided to initiate the New Human Influenza Vaccine R&D project.

    The Science and Technology Team of the National Headquarters for Highly Infectious Avian Flu officially issued the project document. This document lists the New Human Influenza Vaccine R&D project in the first group of projects for Highly Infectious Avian Flu Prevention and Control Programs and assigns the task to China CDC, Sinovac, China National Biotech Corporation, and NICPBP. Moreover, Sinovac and the National Institute for Viral Disease Control and Prevention of China CDC jointly developed the first-ever Inactivated SARS vaccine.

    Related Links:


    Recommend this page: 1 Star2 Stars3 Stars4 Stars5 Stars

    Loading ... Loading ...
    Related News:
  • Sinovac Biotech Commences SARS Vaccine Phase I Human Clinical Testing
  • Sinovac Biotech And CDC Commence New Flu Vaccine Development
  • Sinovac Biotech Ltd First Company To Gain Approval For Clinical Trials On SARS Vaccine
  • Sinovac To Commence Testing Of SARS Vaccine
  • Sinovac Biotech Completes Acquisition Of Tangshan Yian Biological Engineering
  • Sinovac Biotech Ltd. Confirms Name Change and Issues Corporate Update
  • SARS Antibody Sent For Preclinical Testing
  • China Leading The Way In Vaccine Development
  • Anti-cancer Vaccine Approved For Research In Shanghai
  • China Develops Gene Chip



    • Leave A Comment:



    Inside ChinaTechNews.com


      Other China News

      China Sourcing News:

      Home Building Chain Closes Another Store In China

      American Internet Retailer Adds Courier Fees In China

      French Optics Company Announces Two China Investment Deals

      Increasing Manufacturing Costs Cause Trouble For Chinese Retailer
      TechSecurityChina.com:

      Inspur International To Sell Chinese E-government Business

      Shareholder Disputes Settled For Chinese Media Firm

      Qihoo 360′s Safebox Software Will Integrate With Uuu9.com

      Apple Suspends iPhone 4S Sales In Retail Stores In China
      ChinaWirelessNews.com:

      ZTE Launches First Tablet In America

      Apple Adopts New iPhone Sales System In Hong Kong

      China Telecom To Launch CDMA-based iPhone 4S

      China Mobile's Call Center In Luoyang Formally Launched

      Visit these other China sites: ChinaRetailNews.com | GreenChinaTech.com | ChinaWirelessNews.com | TechSecurityChina.com | China Sourcing News | China CSR